albuterol has been researched along with Lupus Erythematosus, Systemic in 3 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muñoz-Rodríguez, FJ | 1 |
| Font, J | 1 |
| Badia, JR | 1 |
| Miret, C | 1 |
| Barberà, JA | 1 |
| Cervera, R | 1 |
| Ingelmo, M | 1 |
| Thompson, PJ | 1 |
| Dhillon, DP | 1 |
| Ledingham, J | 1 |
| Turner-Warwick, M | 1 |
3 other studies available for albuterol and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Research protocol for fetuses with complete heart block. Fetal Cardiology Working Party of the Association of European Pediatric Cardiologists.
Topics: Albuterol; Antibodies, Antinuclear; Betamethasone; Clinical Protocols; Dexamethasone; Europe; Female | 1995 |
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Femal | 1997 |
Shrinking lungs, diaphragmatic dysfunction, and systemic lupus erythematosus.
Topics: Adolescent; Albuterol; Blood Gas Analysis; Diaphragm; Female; Humans; Lung; Lupus Erythematosus, Sys | 1985 |